Cyclacel Pharmaceuticals opened the books on April 2nd, 2025 on the annual quarter of the year on the annual quarter.
A loss per share of $ 0.34 compared to -6.230 in the previous year was announced.
A loss per share of USD $ 2.090 was reported for the year as a whole. In the previous year, $ 26,750 had been generated.
Compared to the previous year, Cyclacel Pharmaceuticals posted a sales drop of 90.48 percent in the past financial year. The turnover was $ 0.04 million compared to $ 0.42 million in the previous year.
Editor finance.net
By the way: Cyclacel Pharmaceuticals and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And receive a free stock as a gift.
Selected leverage products on cyclacel pharmaceuticals
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on cyclacel pharmaceuticals
The lever must be between 2 and 20
Advertising